Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes and hypertension.

B Waeber1, F Feihl, L Ruilope

  • 1Division of Clinical Pathophysiology, University Hospital, Lausanne, Switzerland. bwaeber@chuv.hospvd.ch

Blood Pressure
|February 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triple-combination therapy in the treatment of hypertension: a review of the evidence.

Journal of human hypertension·2017
Same author

Archives of gynecology and obstetrics·2016
Same author

PP125. High mobility group box 1 protein (HMGB1): A pathogenic role in preeclampsia?

Pregnancy hypertension·2015
Same author

Physiological response to whole-body vibration in athletes and sedentary subjects.

Physiological research·2014
Same author

High mobility group box 1 protein (HMGB-1): a pathogenic role in preeclampsia?

Placenta·2014
Same author

[Hypertension. Effects of antihypertensive therapy on cognitive functions].

Revue medicale suisse·2013

Hypertension is common in type 2 diabetes, increasing cardiovascular and kidney risks. Tight blood pressure control and renin-angiotensin system blockade are crucial for protecting diabetic patients with hypertension.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Hypertension frequently coexists with diabetes mellitus, particularly type 2 diabetes.
  • Diabetes itself is a significant risk factor for cardiovascular disease, and hypertension exacerbates this risk.
  • Diabetic nephropathy, characterized by microalbuminuria and progressing to renal failure, is a major complication.

Purpose of the Study:

  • To highlight the importance of blood pressure control in diabetic patients.
  • To review the nephroprotective effects of renin-angiotensin system blockade in hypertensive patients with type 2 diabetes.

Main Methods:

  • Review of recent studies and evidence regarding hypertension in diabetes.
  • Analysis of the role of microalbuminuria as an indicator of endothelial dysfunction and cardiovascular risk.

Related Experiment Videos

  • Evaluation of the impact of angiotensin II antagonists on renal function.

    • Main Results:

    • Tight blood pressure control is essential for cardiovascular and renal protection in diabetic patients.
    • Microalbuminuria indicates renal endothelial dysfunction and predicts cardiovascular risk.
    • Angiotensin II antagonists demonstrate significant nephroprotective effects in hypertensive patients with type 2 diabetes.

    Conclusions:

    • Effective blood pressure management is critical for reducing cardiovascular events and slowing renal disease progression in diabetic individuals.
    • Renin-angiotensin system inhibition offers substantial benefits for kidney protection in this patient population.